IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors
IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors
Recruiting · NCT07508761 · Registry updated 2026-06-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2026-06-29 | NCT07508761 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nanjing Immunophage Biotech Co., Ltd | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai Gaobo Tumor Hospital | Shanghai | China | 1 |